Le Lézard
Classified in: Health
Subject: TRI

Scottsdale Magnesium Study Demonstrates Clinical Effectiveness of the Time-Release Magnesium Supplement MagSRTtm


SCOTTSDALE, Ariz., March 13, 2018 /PRNewswire/ -- A recent clinical study published in the Journal of the American College of Nutrition demonstrated improved absorption, cellular uptake and reduction of Magnesium deficiency symptoms for the time-release Magnesium supplement MagSRTtm. The Scottsdale Magnesium Study showed an improvement of 22 percent for serum Magnesium, an increase of 30 percent for red blood cell (RBC) Magnesium and a reduction of Magnesium deficiency symptoms by 63 percent for individuals receiving MagSRTtm. Furthermore, the MagSRTtm dosage (500 mg/day) was well tolerated by 9 out of 10 participants.

"The Scottsdale Magnesium Study is the first peer-reviewed clinical trial of a time-release Magnesium supplement versus a placebo," said Dr. Decker Weiss, a Naturopathic Cardiologist and principal investigator in the study. "Considering that 75 percent of participants had suboptimal Magnesium levels at baseline, we were extremely pleased about the significant increases in Magnesium serum and Magnesium RBC, and the corresponding decrease in Magnesium deficiency symptoms in the MagSRTtm group."

The Scottsdale Magnesium Study included a standard clinical population of 91 adults in a placebo-controlled study. 53 individuals received MagSRTtm at 500 mg/day, while the remaining participants received a placebo. Baseline measurements were collected prior to trial initiation. Serum Magnesium was measured 4 and 8 hours after participants ingested two tablets (250 mg each) of MagSRTtm or a placebo. After 30 days, RBC Magnesium was evaluated and a Magnesium status questionnaire was completed. A subset of MagSRTtm participants (24) continued the study for 90 days and RBC Magnesium and the questionnaire were again evaluated. 

Key results in the MagSRTtm group were:

MagSRTtm was developed by Jigsaw Health to offer consumers a gentler, better absorbed form of Magnesium. The supplement is based on a proprietary, Sustained Release Technology (w/SRT®) that offers an extended release of Magnesium over time.

"This study confirms what customers have been sharing with us about MagSRTtm," said Patrick Sullivan Jr., co-founder and CEO of Jigsaw Health.  "There's now published data validating why MagSRTtm has been so popular with consumers...it works. Magnesium gets into the Serum and the Red Blood Cells, and people can feel the difference."

About Jigsaw Health

We believe in Air, Water, Magnesium...

Nearly 80% of the population is deficient in Magnesium. And we believe the reason is due to lack of education on what Magnesium does and its essential role in the body. So we've made it part of our mission to provide Magnesium "edu-tainment" ? entertaining educational content.

Since 2005, Jigsaw Health ? "The Magnesium People" ? has been developing science-based dietary supplements with a focus on Magnesium featuring Sustained Release Technology (w/SRT®), which controls the release of active ingredients so absorption can happen over time.

MagSRTtm by Jigsaw Health is America's #1 Time Release Magnesium with over 1,000 five-star Amazon reviews, five times more than the second closest brand.

We believe that life is too short to feel crappy. We believe you CAN feel better. And we believe that laughter is the best medicine...Magnesium is a close second. ;-)

For more information, learn more at the Jigsaw Health web site at http://www.jigsawhealth.com/scottsdale-magnesium-study/

 

SOURCE Jigsaw Health


These press releases may also interest you

at 10:38
Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced the appointment of Mr. John Peterson as the new Vice President of Sales & Marketing, effective immediately....

at 10:30
Endoscopy Equipment Market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029 according to a new report by MarketsandMarketstm. The growth in...

at 10:29
Integrity Marketing Group, LLC ("Integrity"), one of the leading independent distributors of life, health and wealth products, today announced that Integrity Co-Founder and CEO Bryan W. Adams has been recognized as a top CEO for large companies in...

at 10:28
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023. In 2023, Broncus Medical earned product sales of US$12.41 million, an increase of 32% compared to the previous year. Of which, total revenue...

at 10:28
In a groundbreaking leap forward in the realm of nutrition and fitness technology, Portions Master announces the launch of its revolutionary app, set to transform the way individuals approach portion control and nutritional tracking....

at 10:21
Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net loss improved to RMB208.8 million, representing a significant turnaround from a negative...



News published on and distributed by: